Ozempic Face Is Real — What GLP-1 Weight Loss Does to Your Skin and How to Fix It

It started as a whisper on social media, then became a headline: “Ozempic face.” Patients and practitioners began noticing that some people taking GLP-1 receptor agonists for weight loss — like semaglutide — were emerging slimmer, but with faces that looked gaunt, hollow, or prematurely aged. As an aesthetic doctor in Singapore, I’ve seen this pattern firsthand, and it deserves a clear, balanced conversation.

This isn’t an anti-medication piece. GLP-1 medications have transformed the management of obesity and type 2 diabetes, and the clinical data is compelling. But like any significant physiological change, rapid weight loss has downstream effects on the face — and patients deserve to know what those are before they happen, and what can be done.

What Is “Ozempic Face”?

“Ozempic face” describes the facial changes that can occur following rapid or significant weight loss on GLP-1 medications — most commonly semaglutide (Ozempic, Wegovy) or tirzepatide. These changes include: hollowing of the cheeks and temples, deflation under the eyes, loss of jawline definition, jowling, and an overall aged, gaunt appearance — even when the rest of the body looks noticeably slimmer.

The landmark STEP 1 trial, published in the New England Journal of Medicine (Wilding et al., 2021), demonstrated that once-weekly semaglutide produced a mean weight reduction of approximately 14.9% of body weight over 68 weeks. That is a significant, rapid reduction — and the face is not exempt from this fat redistribution.

Why Does the Face Age When You Lose Weight?

The science of facial ageing helps explain this phenomenon. In a landmark anatomical study published in Plastic and Reconstructive Surgery (Rohrich & Pessa, 2007), researchers mapped the discrete fat compartments of the face — demonstrating that facial youthfulness is intimately tied to the volume and position of these compartments. As we age, these compartments deflate and descend. Rapid weight loss accelerates this process by depleting fat across multiple facial zones simultaneously.

The temporal area, midcheek, periorbital region, and jawline are particularly affected. When fat loss is rapid — as can happen with GLP-1 medications — the overlying skin doesn’t have time to contract gradually. The result is skin laxity, visible skeletonisation, and a hollow quality that adds years to the face even as the body looks younger.

“I always counsel patients starting weight loss medications about their face. The goal is to look healthy, not hollow. There are excellent treatments available — but the best time to plan for them is before the weight loss, not after.”

Dr Low Chai Ling, Aesthetic Doctor, SW1 Clinic Singapore

Who Is Most at Risk?

Not everyone who takes a GLP-1 medication will develop significant facial changes. Risk factors include:

• Older age: Skin elasticity declines with age, making it harder to accommodate rapid volume loss.
• Rapid rate of weight loss: The faster the loss, the less time the skin has to adapt.
• Pre-existing laxity: Patients who already have early facial sagging are more susceptible.
• Higher starting weight: Greater fat stores mean greater potential loss.

What Aesthetic Treatments Can Help?

The good news: these changes are treatable. At SW1 Clinic, we approach Ozempic face with a combination strategy tailored to each patient’s specific pattern of change.

• Hyaluronic acid fillers: Carefully placed in the cheeks, temples, and periorbital region to restore lost volume and redefine facial contours. A skilled injector uses conservative amounts to achieve a natural result — not the overfilled look, but restored balance.
• Bio-remodelling skin boosters: For patients with skin quality changes — laxity, crepe-like texture — bio-stimulatory boosters can improve skin firmness and hydration without adding visible volume.
• Skin tightening: Ultrasound-based technologies that work at the deep structural level to lift and tighten skin are particularly valuable for patients with facial laxity. Ultherapy Prime uses focused ultrasound energy to stimulate collagen remodelling at multiple tissue depths — addressing laxity from the inside out.
• Collagen-stimulating treatments: Treatments like Heaven Glow can complement structural restoration by improving overall skin quality, radiance, and resilience.

When Should You Start Thinking About This?

Ideally, before you begin significant weight loss. At SW1 Clinic, I recommend patients starting GLP-1 medications come in for a baseline facial assessment. We can then map out a preventive strategy — often starting with skin quality treatments early in the weight loss journey, and addressing volume as needed once weight stabilises.

The goal is never to look untouched by time. The goal is to look like the best version of yourself — healthy, radiant, and balanced. Weight loss is a significant achievement. Your face should reflect that, not undermine it.

References

• Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989–1002.
• Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119(7):2219–2227.
• Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin. Am J Pathol. 2006;168(6):1861–1868.

Not sure where to start? Take the SW1 quick quiz to find the right treatment for your skin. Or reach out to our front desk on WhatsApp at +65 8089 8669 — we handle enquiries in English and Mandarin.